These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 36059987)

  • 21. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
    Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders.
    Williams OOF; Coppolino M; George SR; Perreault ML
    Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia.
    Abramsky O; Litvin Y
    Perspect Biol Med; 1978; 22(1):104-14. PubMed ID: 733451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural insights into the human D1 and D2 dopamine receptor signaling complexes.
    Zhuang Y; Xu P; Mao C; Wang L; Krumm B; Zhou XE; Huang S; Liu H; Cheng X; Huang XP; Shen DD; Xu T; Liu YF; Wang Y; Guo J; Jiang Y; Jiang H; Melcher K; Roth BL; Zhang Y; Zhang C; Xu HE
    Cell; 2021 Feb; 184(4):931-942.e18. PubMed ID: 33571431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The D3 dopamine receptor in cellular and organismal function.
    Shafer RA; Levant B
    Psychopharmacology (Berl); 1998 Jan; 135(1):1-16. PubMed ID: 9489928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target identification for CNS diseases by transcriptional profiling.
    Altar CA; Vawter MP; Ginsberg SD
    Neuropsychopharmacology; 2009 Jan; 34(1):18-54. PubMed ID: 18923405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function.
    Belkacemi L; Darmani NA
    Pharmacol Res; 2020 Nov; 161():105124. PubMed ID: 32814171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease.
    Mishra A; Singh S; Shukla S
    J Exp Neurosci; 2018; 12():1179069518779829. PubMed ID: 29899667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptors--physiological understanding to therapeutic intervention potential.
    Emilien G; Maloteaux JM; Geurts M; Hoogenberg K; Cragg S
    Pharmacol Ther; 1999 Nov; 84(2):133-56. PubMed ID: 10596903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
    Hayashi T; Su TP
    CNS Drugs; 2004; 18(5):269-84. PubMed ID: 15089113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D
    Hui Y; Du C; Xu T; Zhang Q; Tan H; Liu J
    Neurochem Int; 2020 Nov; 140():104844. PubMed ID: 32891683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential therapeutic targets for Parkinson's disease.
    Stoessl J
    Expert Opin Ther Targets; 2008 Apr; 12(4):425-36. PubMed ID: 18348679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.
    Berg KA; Clarke WP; Cunningham KA; Spampinato U
    Neuropharmacology; 2008 Nov; 55(6):969-76. PubMed ID: 18602407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease.
    Chen APF; Chen L; Kim TA; Xiong Q
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34200134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states.
    Sgambato-Faure V; Tremblay L
    J Neural Transm (Vienna); 2018 Mar; 125(3):485-500. PubMed ID: 28176009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.